These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I. Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405 [Abstract] [Full Text] [Related]
8. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. Feoktistov I, Biaggioni I. Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117 [Abstract] [Full Text] [Related]
10. Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure. Newland MC, Brown K. Behav Pharmacol; 1997 Feb; 8(1):17-30. PubMed ID: 9832997 [Abstract] [Full Text] [Related]
11. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M. J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819 [Abstract] [Full Text] [Related]
12. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor. Levens N, Beil M, Jarvis M. J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017 [Abstract] [Full Text] [Related]
19. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist. Barrett RJ, May JM, Martin PL, Miller JR. J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236 [Abstract] [Full Text] [Related]